Sedia

US-based healthcare firm Sedia Biosciences has launched the Asanté DNA specimen collection kit and the Asanté DNA purification kit.

The specimen collection kit is claimed to have low DNA retention, minimal interfering substances and ease of use, and is designed as a cost-competitive alternative to current methods.

In order to facilitate extraction, purification and concentration of DNA from the kit, Sedia has also launched the purification kit.

The kit has been developed to collect oral DNA specimens with minimal downstream processing or extraneous reagent introduction, while maximising DNA yield.

"The Asante DNA kit has been developed to collect oral DNA specimens with minimal downstream processing."

Research investigators who evaluated the product during development found that it can be used to collect DNA from a variety of tissue types and locations, including genitourinary tract specimens, cadaverous samples, tissue speciation and identification, food pathogen testing, and other biological fluid characterisations.

Sedia Biosciences president and chief science officer Ronald Mink said: "Our Asanté DNA specimen collection kit is built upon our expertise in assay development, where we have identified low binding matrices that can be used to readily take up and release DNA, as well as other analytes.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

"This has reduced the need for abrasive materials, hazardous chemical reagents or extreme concentration methods used by other manufacturers to obtain adequate DNA samples and enabled us to produce a lower-cost DNA collection device."

Sedia Biosciences CEO Roger Gale said: "We are excited about our entry into the DNA collection device market, and optimistic that our product can compete internationally against other products that perform less effectively and cost more."

The device offers samples, which are suitable for testing by most in-vitro DNA amplification methods, including the polymerase chain reaction (PCR) and modifications, pretreatments and extensions, helicase-dependent amplification (HDA), ligase chain reaction (LCR), and the loop-mediated isothermal amplification (LAMP).


Image: The Asanté DNA Specimen Collection Kit from Sedia Biosciences. Photo: courtesy of Business Wire / Sedia Biosciences Corporation.